Tesamorelin Peptide

Tesamorelin Peptide. Tesamorelin is a growth hormone–releasing hormone (GHRH) analogue used in controlled in-vitro studies of GHRH receptor signalling, cAMP/PKA pathways, and GH-axis models under non-clinical laboratory conditions.

Tesamorelin

This peptide is a stabilised analogue of human GHRH(1–44). Consequently, laboratories select it to explore ligand–receptor engagement, downstream second-messenger responses, and assay readouts relevant to somatotropic signalling in model systems.
For laboratory research only. Not for human use.

Tesamorelin Key features

• GHRH analogue for in-vitro studies of GHRHR signalling and GH-axis biology.
• Supplied as a lyophilised solid for stability and straightforward storage.
• Unit size: 5 mg per vial.
• Each batch released only after stringent quality checks.

Specifications

• Product name: Tesamorelin
• Synonyms: TH9507; GHRH(1–44) analogue
• Class: Peptide analogue of growth hormone–releasing hormone
• Form: Lyophilised powder
• Appearance: White to off-white solid
• Note: Exact properties may vary by counterion/hydration state.

Handling & storage

1. Storage (dry): Keep vials protected from light and moisture.
2. Reconstitution: Bring vial and diluent to room temperature. Reconstitute with
   Bacteriostatic Water 10 ml. Swirl gently — do not vortex.
3. After reconstitution: Store at 2–8 °C, protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling.
4. Compatibility: Use only within research protocols that follow your lab’s SOPs and local regulations.

Looking for complementary materials? See
Bacteriostatic Water 10 ml and GH-axis research companions such as
CJC-1295 5 mg and
Ipamorelin 5 mg.

About tesamorelin in research

Researchers employ tesamorelin to probe GHRH receptor (GHRHR) engagement and downstream signalling, including cAMP accumulation, PKA activation, and associated transcriptional responses. Studies focus on receptor pharmacology and pathway mapping exclusively in controlled, non-clinical in-vitro environments.

Synthesis & quality

Manufactured via controlled, validated peptide-synthesis processes to deliver high purity and lot-to-lot consistency. Each batch undergoes identity, purity, and appearance checks before release.
Certificates of Analysis (CoA) are available on request.

Legal & safety

XL Peptides supplies materials strictly for laboratory research. Products are not medications, foods, supplements, or cosmetics; not for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will handle the material in line with your institution’s policies and applicable laws.

Tesamorelin Peptide

FAQs

What is tesamorelin?
A stabilised analogue of human GHRH(1–44) used to study GHRHR signalling and GH-axis pathways in vitro.

How should I store the peptide?
Keep lyophilised vials away from light and moisture. After reconstitution, store at 2–8 °C, protect from light, and avoid repeated temperature cycling.

What diluent should I use?
Many labs use
Bacteriostatic Water 10 ml. Always follow your lab’s SOPs.

Do you provide documentation?
Yes. Batch documentation (e.g., Test Results) is available on request; if it’s not attached below, contact support and we’ll add it to your order.

Tesamorelin Peptide

Is this product for human use?
No. This material is for research only and is not intended for human consumption or clinical applications.

External resources for researchers

• PubChem — Tesamorelin (search)
• PubMed — Tesamorelin / GHRH analogue (search)

Related research peptides

• CJC-1295 5 mg
• Ipamorelin 5 mg
• Bacteriostatic Water 10 ml

Disclaimer

Used solely for in vitro experiments and cannot be:

– Used in clinical trials involving humans
– Administered to humans as part of an experiment or investigation
– Supplied to another party for human investigational use

Tesamorelin Peptide